Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Forest M White

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Molecular & Cellular Proteomics : MCP|September 12, 2012
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenograftsHannah Johnson, Amanda M Del Rosario, Bryan D Bryson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Early signaling dynamics of the epidermal growth factor receptorRaven J Reddy, Aaron S Gajadhar, Eric J Swenson, et al.
Molecular Biosystems|December 17, 2008
An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cellsBrian A Joughin, Kristen M Naegle, Paul H Huang, et al.
Molecular & Cellular Proteomics : MCP|June 14, 2005
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modulesYi Zhang, Alejandro Wolf-Yadlin, Phillip L Ross, et al.
Molecular Cancer Therapeutics|August 24, 2017
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B Emdal, Antje Dittmann, Raven J Reddy, et al.
Molecular Cancer Therapeutics|May 20, 2016
Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S Lescarbeau, Liang Lei, Katrina K Bakken, et al.
Cancer Research|January 29, 2021
High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human TumorsLauren E Stopfer, Cameron T Flower, Aaron S Gajadhar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recyclingJamie B Spangler, Jason R Neil, Sivan Abramovitch, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibitionCameron T Flower, Chunmei Liu, Hui-Yu Chuang, et al.
Cell Reports|November 29, 2018
Microtubule-Based Control of Motor-Clutch System Mechanics in Glioma Cell MigrationLouis S Prahl, Patrick F Bangasser, Lauren E Stopfer, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Molecular & Cellular Proteomics : MCP|September 12, 2012
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenograftsHannah Johnson, Amanda M Del Rosario, Bryan D Bryson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Early signaling dynamics of the epidermal growth factor receptorRaven J Reddy, Aaron S Gajadhar, Eric J Swenson, et al.
Molecular Biosystems|December 17, 2008
An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cellsBrian A Joughin, Kristen M Naegle, Paul H Huang, et al.
Molecular & Cellular Proteomics : MCP|June 14, 2005
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modulesYi Zhang, Alejandro Wolf-Yadlin, Phillip L Ross, et al.
Molecular Cancer Therapeutics|August 24, 2017
Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of ResistanceKristina B Emdal, Antje Dittmann, Raven J Reddy, et al.
Molecular Cancer Therapeutics|May 20, 2016
Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S Lescarbeau, Liang Lei, Katrina K Bakken, et al.
Cancer Research|January 29, 2021
High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human TumorsLauren E Stopfer, Cameron T Flower, Aaron S Gajadhar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recyclingJamie B Spangler, Jason R Neil, Sivan Abramovitch, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibitionCameron T Flower, Chunmei Liu, Hui-Yu Chuang, et al.
Cell Reports|November 29, 2018
Microtubule-Based Control of Motor-Clutch System Mechanics in Glioma Cell MigrationLouis S Prahl, Patrick F Bangasser, Lauren E Stopfer, et al.
Pageof 17